| dc.contributor.author | Damjanov, Dimitrije | |
| dc.contributor.author | Stojčević Maletić, Jelena | |
| dc.contributor.author | Petrović, Tamaš | |
| dc.contributor.author | Savić, Željka | |
| dc.contributor.author | Knežević, Milica | |
| dc.contributor.author | Gajdov, Vladimir | |
| dc.contributor.author | Ružić, Maja | |
| dc.date.accessioned | 2026-07-13T11:30:14Z | |
| dc.date.available | 2026-07-13T11:30:14Z | |
| dc.date.issued | 2026-05 | |
| dc.identifier.citation | Damjanov, D., Maletić, J.S., Petrović, T. et al. Hepatitis E virus seroprevalence and infection status among patients with inflammatory bowel disease undergoing advanced therapy: a prospective single-center observational study. BMC Gastroenterol 26, 415 (2026). https://doi.org/10.1186/s12876-026-04907-1 | en_US |
| dc.identifier.issn | 1471-230x | |
| dc.identifier.uri | https://repo.niv.ns.ac.rs/xmlui/handle/123456789/1140 | |
| dc.language.iso | en | en_US |
| dc.publisher | Springer Nature Link | en_US |
| dc.source | BMC Gastroenterology | en_US |
| dc.subject | Hepatitis E | en_US |
| dc.subject | Inflammatory bowel disease | en_US |
| dc.subject | Biologic therapy | en_US |
| dc.title | Hepatitis E virus seroprevalence and infection status among patients with inflammatory bowel disease undergoing advanced therapy: a prospective single-center observational study | en_US |
| dc.type | Article | en_US |
| dc.identifier.doi | 10.1186/s12876-026-04907-1 | |
| dc.citation.volume | 26 | en_US |
| dc.citation.spage | 415 | en_US |
| dc.citation.rank | M22 | en_US |
| dc.type.version | published | en_US |